Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Oct 17, 2023 1:30 PM - Oct 17, 2023 5:30 PM

(Central Europe Standard Time)

EMA Clinical Trial Information System (CTIS) Information Day

The virtual event aims to support sponsors of clinical trials in preparing and proceeding with the transition of their clinical trials to meet the deadline of 30 January 2025. Commercial and non-commercial sponsors with experience in transitioning trials as well as representatives from EMA and EU/EEA member states will share insights and best practices.

Overview

The Clinical Trials Information System (CTIS) is the backbone of the Clinical Trials Regulation (Regulation (EU) No 536/2014) and acts as a the single-entry point for clinical trials assessment, authorisation and supervision in the EEA.

It also enables the publication and registration of clinical trials in the CTIS public website that is a public register with search and download functionalities.

CTIS provides harmonised and simplified end-to-end electronic application procedures over the lifecycle of clinical trials across the EU/EEA.

Since the launch of CTIS on 31 January 2023, only 15 months remain to transition ongoing trials from the previous legislative framework of the Clinical Trials Directive (2001/20/EC) to the Clinical Trial Regulation (536/2014).

The virtual event aims to support sponsors of clinical trials in preparing and proceeding with the transition to meet the deadline of 30 January 2025. Commercial and non-commercial sponsors with experience in transitioning trials as well as representatives from EMA and EU/EEA member states will share insights and best practices.

Ample time is foreseen for Q&A. The faculty invites participants to submit related questions by 03 October 2023 latest to emaevents@diaglobal.org

 

Featured topics

  • Transition period from the Clinical Trials Directive (2001/20/EC) to the Clinical Trial Regulation – regulatory and practical aspects
  • Insights on preparation for transitioning clinical trials from sponsors’ perspective
  • Insights on member states procedures with regard to transitioning of clinical trials
  • CTIS system metrics
  • Upcoming training and event opportunities

Who should attend?

This EMA CTIS Virtual Information Day is aimed at CTIS users from:

  • Pharmaceutical companies
  • Small and medium sized enterprises (SMEs)
  • Academic organisations
  • Contract Research Organisations (CROs)
  • Member State NCAs
  • Ethics Committee Members

Program Committee

  • Peter Richard Arlett, MD, FFPM, FRCP
    Peter Richard Arlett, MD, FFPM, FRCP Head Data Analytics and Methods Task Force
    European Medicines Agency, Netherlands
  • Marianne  Lunzer, DrMed
    Marianne Lunzer, DrMed Assessor, Dept of Clinical Trials, Federal Office for Safety in Health Care
    AGES, Austria
  • Noemie  Manent, PharmD
    Noemie Manent, PharmD TDA-CTT Operations Workstream Lead
    European Medicines Agency, Netherlands

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.